Countdown to Alcon (ALC) Q2 Earnings: Wall Street Forecasts for Key Metrics

Core Insights - Alcon (ALC) is expected to report quarterly earnings of $0.74 per share, a 7.3% increase year-over-year, with revenues projected at $2.52 billion, reflecting a 4.8% year-over-year growth [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of projections [1] - Analysts emphasize the importance of earnings projections in predicting investor reactions and stock price movements [1] Financial Metrics - 'Net Sales- Total Surgical' is estimated to be $1.43 billion, representing a 3.8% year-over-year increase [2] - 'Net Sales- Total Vision Care' is projected to reach $1.08 billion, indicating a 6.1% year-over-year growth [2] - 'Net Sales- Total Surgical- Consumables' is expected to be $747.78 million, reflecting a 4.7% year-over-year increase [2] Additional Sales Estimates - 'Net Sales- Total Surgical- Equipment/other' is forecasted at $230.63 million, showing a slight decline of 0.2% year-over-year [3] - 'Net Sales- Total Vision Care- Contact lenses' is projected to be $642.70 million, indicating an 8.2% year-over-year increase [3] - 'Net Sales- Total Vision Care- Ocular health' is expected to reach $439.09 million, reflecting a 3.1% year-over-year growth [3] - 'Net Sales- Total Surgical- Implantables' is estimated at $456.57 million, indicating a 4.5% year-over-year increase [3] Stock Performance - Over the past month, Alcon shares have returned +4%, outperforming the Zacks S&P 500 composite, which declined by -2.9% [3] - Alcon currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [3]